Main container

Ibrahim Toni, BSc, MSc, MD, PhD

CV

Date of Birth
01/09/1968
Qualification

BSc, MSc, MD, PhD

Current assignment

Director of the "complex structure" Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies (resolution no.99 of the april 9th 2021)

Coordinator of Pathways, Networks and Oncological Research IOR (resolution no.105 of the april 14th 2021)

Title of qualification awarded
  • Degree in Biological Sciences (BSc) with Master (MSc) in Physiology (Lebanese University of Beirut, Lebanon, 1989)
  • Degree in Medicine with Honours (110/110) (University of Ferrara, Italy, 1996)
Other qualifications awarded
  • Specialization in Medical Oncology with Honours (50/50) (University of Ferrara, Italy, 2000)
  • Admitted to practice and member of the Order of Physicians in the Forlì-Cesena Province, Italy (1997-present)
  • Qualified to the management of Complex Structures of Healthcare at 9th dec 2015 at the University of Ferrara and the Emilia-Romagna Region
  • PhD in Experimental and Clinical Oncology (University of Modena and Reggio Emilia, Italy, 2009)
  • Master of Science (MSc) degree in Osteoncolgy (University of Modena and Reggio Emilia, Italy, 2005)
Positions held
  • Coordinator of the multidisciplinary group of Head and Neck Cancer and Rare Tumors of The Comprehensive Cancer Care Network- AUSL Romagna/IRST- IRCCS, of Romagna, Italy. (15 Feb 2018- 09 May 2021)
  • From May 10 th 2021, at IRCCS Istituto Ortopedico Rizzoli (Rizzoli Orthopedic Institute IOR), Bologna:  Director of “Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit” which include 6 Oncologists, 11 Lab Researchers and 2 Study Coordinators; Coordinator of Multidisciplinary Groups and Networks in Osteoncology and Sarcomas and Coordinator of Translational Oncologic Research at IOR.
  • Permanent contract form Feb 2008 with IRST- IRCCS and Head of the Osteoncology and Rare Tumors Center (CDO-TR), until May 09 th 2021, which include 6 Oncologists and 7 Lab Researchers. The CDO-TR is a Center of Excellence for ISO (Italian Society of Osteoncology) criteria and member of National Network of Osteoncology and Rare Tumors and EURACAN  (EUropean RAre CANcers). Head of  the Unit (April 2020- May 2021): Immunotherapy, Somatic Cellular Therapy and Biobank (ITCB) which include 3 Oncologists, 5 Lab reasearchers, the Immuno-Gene Therapy Factroy include 4 biologists and 4 lab tecnicians, The Biobank include 3 biologists and 1 lab tecnician. Dr Ibrahim coordinate 32 professionals. The CDO-TR and ITCB offering mono and multidisciplinary assistance, basic and translational research and training program
  • Head of Immunotherapy, Somatic Cellular Therapy and Biobank, IRST-IRCCS (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Meldola (April 2020-09 May 2021).
  • Founder and Head of Rare Tumors Center , IRST-IRCCS (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Meldola (Jan 2011-09 May 2021).
  • Founder and Head of the Osteoncology Center, IRST-IRCCS (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Meldola (20 Jan 2005-09 May 2021).
  • Visiting Scientist from 07/02/12 to 07/28/12 at The Methodist Hospital Research Institute, Houston- Texas, USA , from 07/30/12 at 08/11/12 at Molecular Department, Princeton University, Princeton- New Jersey, USA and form 10/12/2014 at 10/22/2014 at the Urology department of Leiden University Medical center, The Netherlands.
  • Medical Director of Sanibel Srl Polyclinic, Meldola (FC), Italy, a subsidized private health facility with the National Health Service (Jul 2003-Feb 2005)
  • Freeleance contract with AIL (Italian Association against Leukemia, Forlì-Cesena branch), treating Oncohaematology patients (blood trasfusions etc) in the Forlì province, Italy (Oct-Dec 2001)
  • Various freelance and fixed-term contracts (Istituto Oncologico Romagnolo) at Pierantoni Hospital, Forlì, Italy: Medical Oncology Dept - Medical Oncologist with clinical (inpatient, Day Hospital, outpatient clinic, and home care) and research responsibilites (phase I-IV, in Good Clinical Practice) (1997-2008)
  • Post-graduate training at S. Anna hospital, Ferrara, Italy: Medical Oncology Dept, General Surgery, Institute of Clinical Obstetrics & Gynecology, A&E, and Laboratory of the Institute of Anatomy and Histology (1996-1997)
  • Participant in a course in Cellular Biology at the Laboratory of Cellular Biology (Istituto di Anatomia Umana Normale, University of Ferrara, Italy) during the academic year 1990-1991
Languages
  • Arabic: mother tongue
  • Italian, English and French: good
Scientific activities

From June 25th 2021 Vice President of the Italian Sarcoma Group.

Content updated
19/04/2022 16:51